These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16388362)

  • 1. Immunological markers in multiple sclerosis: tackling the missing elements.
    Rinaldi L; Gallo P
    Neurol Sci; 2005 Dec; 26 Suppl 4():S215-7. PubMed ID: 16388362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of biomarkers in multiple sclerosis.
    Bielekova B; Martin R
    Brain; 2004 Jul; 127(Pt 7):1463-78. PubMed ID: 15180926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies as biological markers for pathophysiological processes in MS.
    Reindl M; Khalil M; Berger T
    J Neuroimmunol; 2006 Nov; 180(1-2):50-62. PubMed ID: 16934337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to myelin oligodendrocyte glycoprotein as a biomarker in multiple sclerosis--are we there yet?
    Amor S; Giovannoni G
    Mult Scler; 2007 Nov; 13(9):1083-5. PubMed ID: 17967836
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of association between antimyelin antibodies and progression to multiple sclerosis.
    Berger T; Reindl M
    N Engl J Med; 2007 May; 356(18):1888-9; author reply 1888-9. PubMed ID: 17476020
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiplexing approaches for autoantibody profiling in multiple sclerosis.
    Somers K; Govarts C; Stinissen P; Somers V
    Autoimmun Rev; 2009 Jun; 8(7):573-9. PubMed ID: 19393211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do myelin-directed antibodies predict multiple sclerosis?
    Antel JP; Bar-Or A
    N Engl J Med; 2003 Jul; 349(2):107-9. PubMed ID: 12853581
    [No Abstract]   [Full Text] [Related]  

  • 8. [Multiple sclerosis. Biomarkers for deciding treatment].
    Meinl E; Voltz R
    MMW Fortschr Med; 2004 May; 146 Spec No 2():57-8. PubMed ID: 15376703
    [No Abstract]   [Full Text] [Related]  

  • 9. An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis.
    Lolli F; Mulinacci B; Carotenuto A; Bonetti B; Sabatino G; Mazzanti B; D'Ursi AM; Novellino E; Pazzagli M; Lovato L; Alcaro MC; Peroni E; Pozo-Carrero MC; Nuti F; Battistini L; Borsellino G; Chelli M; Rovero P; Papini AM
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10273-8. PubMed ID: 16014416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myelin oligodendrocyte glycoprotein (MOG) antibody and demyelination].
    Fukaura H
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():637-40. PubMed ID: 20942151
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood test may predict MS progression.
    Health News; 2003 Sep; 9(9):5-6. PubMed ID: 14584469
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of autoantibodies associated with myelin damage in multiple sclerosis.
    Genain CP; Cannella B; Hauser SL; Raine CS
    Nat Med; 1999 Feb; 5(2):170-5. PubMed ID: 9930864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viability of autoantibody-targets: how to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosis.
    Mayer MC; Hohlfeld R; Meinl E
    J Neurol Sci; 2012 Aug; 319(1-2):2-7. PubMed ID: 22647585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
    Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimyelin antibodies with no progression to multiple sclerosis.
    Pelayo R; Tintoré M; Montalban X; Rovira A; Espejo C; Reindl M; Berger T
    N Engl J Med; 2007 Jan; 356(4):426-8. PubMed ID: 17251547
    [No Abstract]   [Full Text] [Related]  

  • 16. T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein.
    de Rosbo NK; Ben-Nun A
    J Autoimmun; 1998 Aug; 11(4):287-99. PubMed ID: 9776706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults.
    Wang H; Munger KL; Reindl M; O'Reilly EJ; Levin LI; Berger T; Ascherio A
    Neurology; 2008 Oct; 71(15):1142-6. PubMed ID: 18753473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-MOG immunoglobulin IgM].
    Fukaura H; Kikuchi S
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():593-5. PubMed ID: 16111341
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimyelin antibodies in multiple sclerosis.
    Mantegazza R
    N Engl J Med; 2003 Dec; 349(23):2269-71; author reply 2269-71. PubMed ID: 14663868
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.
    Menge T; Lalive PH; von Büdingen HC; Cree B; Hauser SL; Genain CP
    J Allergy Clin Immunol; 2005 Aug; 116(2):453-9. PubMed ID: 16083805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.